Last reviewed · How we verify
NCT06863909
Study on the Effectiveness of Journaling as an add-on to Cognitive Behavioral Therapy
NA trial testing Journaling in Affective Disorders in 80 participants. Enrolling by invitation.
31 December 2026
Quick facts
| Lead sponsor | University Hospital Tuebingen |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 20 November 2024 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Journaling
- Treatment as Usual (TAU) — full drug profile →
Conditions studied
- Affective Disorders — all drugs for Affective Disorders →
- Rumination — all drugs for Rumination →
- Childhood Trauma — all drugs for Childhood Trauma →
- Eating Disorder — all drugs for Eating Disorder →
Sponsor
University Hospital Tuebingen
Who can join
Adults 18 to 65, any sex, with Affective Disorders or Rumination. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the present study is to examine the effects of keeping a therapy journal (journaling) on the effectiveness of cognitive behavioral therapy (CBT). Homework assignments are a fundamental component of behavioral therapies. In line with the learning theory foundation of behavioral therapies, various types of homework are used to facilitate learning processes between therapy sessions and to enable patients to make progress. One way to enhance individual goal setting and reflection in patients is through the use of "therapy journals." The goal of the planned project is to evaluate the effectiveness of goal-oriented journal writing as an additional element in cognitive behavioral therapy (CBT). To do this, psychotherapy patients will be randomly assigned to two treatment groups: CBT vs. CBT + Journaling. Patients will be block-randomized until 40 patients have completed the study in each treatment arm (at least 10 completed sessions).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06863909
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Journaling
Trials testing the same drug.
- NCT06539949 — Efficacy of the Tony Robbins Rapid Planning Method (RPM) · NA · completed
- NCT05833269 — Intercare, Mindfulness and Compassion Based Intervention for Parental Burnout · NA · active not recruiting
- NCT04331925 — Impact of Journal Program on Wellbeing of NICU Parents · NA · completed
- NCT03177655 — Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis · NA · completed
Other recruiting trials for Affective Disorders
Currently open trials in the same condition.
- NCT06738953 — Prevention of Mental Disorders Through Self-efficacy Interventions · NA · recruiting
Other University Hospital Tuebingen trials
Trials by the same sponsor.
- NCT07378670 — DEfeating PEnile CAncer-2 · NA · recruiting
- NCT07276503 — Verification of a New Predictive Delirium Score in Adults With Elective Cardiac Valve or Bypass Surgery With Perioperati · not yet recruiting
- NCT07411365 — Dual-task Cognitive-motor Telerehabilitation in Persons With PD-MCI · NA · not yet recruiting
- NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
- NCT07378891 — Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI) · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06863909 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Tuebingen
- Last refreshed: 8 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06863909.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing